Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
Valkyrie Clinical Trials, Los Angeles, California Winship Cancer Institute, Atlanta, Georgia Hackensack University Medical Center, Hackensack, New Jersey